Press release
Align Technology Announces Fourth Quarter and Fiscal 2024 Financial Results
Q4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion Q4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year,
About this update from Align Technology, Inc.
[{"type":"text","content":"\nQ4 total revenues of $995.2 million and FY2024 total revenues of $4.0 billion\n\n\nQ4 and FY2024 total revenues up 4.0% year-over-year and up 3.5% year-over-year, respectively\n\n\nQ4 Clear Aligner volumes up 1.9% sequentially, and up 6.1% year-over-year\n\n\nQ4 Systems and Services revenues up 5.2% sequentially, and up 14.9% year-over-year\n\n\n\n2024 total revenues of $4.0 billion, Clear Aligner revenues of $3.2 billion and Systems and Services revenues of $768.9 million\n\n\n\n2024 revenues were unfavorably impacted by foreign exchange of approximately $38.5 million compared to 2023(1)\n\n\n\n2024 operating margin of 15.2%, non-GAAP operating margin of 21.8%, and diluted net income per share of $5.62, non-GAAP diluted net income per share of $9.33\n\n\n\n2024 operating margin was unfavorably impacted by foreign exchange of approximately 0.7 points compared to 2023(1)\n\n\n\nRepurchased $352.9 million of common stock in 2024\n\n\n\nQ4'24 total revenues of $995.2 million, and diluted net income per share of $1.39, non-GAAP diluted net income per share of $2.44\n\n\n\nQ4’24 diluted net income per share was unfavorably impacted by a stronger U.S. dollar, which amounted to approximately $0.14 per diluted share due to net foreign exchange losses related to the revaluation of certain balance sheet accounts\n\n\n\nQ4'24 revenues were favorably impacted by foreign exchange of approximately $0.8 million sequentially and unfavorably impacted by approximately $0.9 million year-over-year(1)\n\n\n\nQ4'24 restructuring and other charges of $37.0 million, primarily related to post-employment benefits\n\n\n\n TEMPE, Ariz.--(BUSINESS WIRE)--\nAlign Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the fourth quarter (\"Q4'24\") and year ended December 31, 2024 (\"2024\"). Q4'24 total revenues were $995.2 million, up 1.8% sequentially and up 4.0% year-over-year. Q4'24 total revenues were favorably impacted by foreign exchange of approximately $0.8 million or 0.1% sequentially and unfavorably impacted by approximately $0.9 million or 0.1% year-over-year.(1) Q4'24 Clear Aligner revenues were $794.3 mi...